Dr. Paul Stokes

Publications


Journals

  • Stokes PR; Egerton A; Watson B; Reid A; Lappin J; Howes OD; Nutt DJ; Lingford-Hughes AR. (Jan 2012). History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability. J Psychopharmacol. 26:144-149. DOI.
  • Shotbolt P; Stokes PR; Owens SF; Toulopoulou T; Picchioni MM; Bose SK; Murray RM; Howes OD. (Nov 2011). Striatal dopamine synthesis capacity in twins discordant for schizophrenia. Psychol Med. 41:2331-2338. DOI.
  • Ball G; Stokes PR; Rhodes RA; Bose SK; Rezek I; Wink AM; Lord LD; Mehta MA; et alGrasby PM; Turkheimer FE. (2011). Executive functions and prefrontal cortex: a matter of persistence?. Front Syst Neurosci. 5:3. DOI.
  • Stokes PR; Rhodes RA; Grasby PM; Mehta MA. (Mar 2011). The effects of the COMT Val108/158Met polymorphism on BOLD activation during working memory, planning, and response inhibition: a role for the posterior cingulate cortex?. Neuropsychopharmacology. 36:763-771. DOI.
  • Selvaraj S; Godlewska BR; Norbury R; Bose S; Turkheimer F; Stokes P; Rhodes R; Howes O; et alCowen PJ. (May 2011). Decreased regional gray matter volume in S' allele carriers of the 5-HTTLPR triallelic polymorphism. Mol Psychiatry. 16:471-473. DOI.
  • Egerton A; Rees E; Bose SK; Lappin JM; Stokes PR; Turkheimer FE; Reeves SJ. (1 Nov 2010). Truth, lies or self-deception? Striatal D(2/3) receptor availability predicts individual differences in social conformity. Neuroimage. 53:777-781. DOI.
  • Stokes PR; Egerton A; Watson B; Reid A; Breen G; Lingford-Hughes A; Nutt DJ; Mehta MA. (1 Oct 2010). Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage. 52:1521-1527. DOI.
  • Egerton A; Shotbolt JP; Stokes PR; Hirani E; Ahmad R; Lappin JM; Reeves SJ; Mehta MA; et alHowes OD; Grasby PM. (Mar 2010). Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. Neuroimage. 50:260-266. DOI.
  • Stokes PRA; Mehta MA; Curran HV; Breen G; Grasby PM. (15 Oct 2009). Can recreational doses of THC produce significant dopamine release in the human striatum?. NEUROIMAGE. 48:186-190. DOI.
  • Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S. (2009). Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des. 15:2550-2559.
  • Bose SK; Turkheimer FE; Howes OD; Mehta MA; Cunliffe R; Stokes PR; Grasby PM. (Dec 2008). Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging. SCHIZOPHR RES. 106:148-155. DOI.
  • Montgomery AJ; Stokes P; Kitamura Y; Grasby PM. (Aug 2007). Extrastriatal D-2 and striatal D-2 receptors in depressive illness: Pilot PET studies using [C-11]FLB 457 and [C-11]raclopride. J AFFECT DISORDERS. 101:113-122. DOI.
  • Steward LJ; Ge J; Stowe RL; Brown DC; Bruton RK; Stokes PR; Barnes NM. (1996). Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo. Br J Pharmacol. 117:55-62. Author weblink.

Conferences

  • Benecke A; Shotbolt JP; Egerton A; Nutt D; Lingford-Hughes AR; Howes O; Stokes PRA. DOES PRESYNAPTIC STRIATAL DOPAMINE SYNTHESIS CAPACITY PREDICT SOCIALLY DESIRABLE RESPONDING?. 25:A42-A42. (Aug 2011).
  • Stokes PR; Clark L; Wu K; Michalczuk R; Watson B; Egerton A; Lappin J; Piccini P; et alNutt D; Bowden-Jones H; Lingford-Hughes A. IMAGING THE DOPAMINE SYSTEM IN PATHOLOGICAL GAMBLING: AN [11C]-RACLOPRIDE PET STUDY. 25:A61-A61. (Aug 2011).
  • Godlewska BR; Selvaraj S; Norbury R; Bose S; Turkheimer F; Richards G; Brownseu S; Stokes P; et alRhodes R; Howes O; Cowen P. S' ALLELE CARRIERS OF THE 5-HTTLPR TRIALLELIC POLYMORPHISM HAVE LOWER FRONTAL, SUPERIOR TEMPORAL AND CINGULATE GYRI VOLUMES: A 3T VBM STUDY. 24:A37-A37. (Aug 2010).
  • Stokes PRA; Shotbolt JP; Copeland C; Nutt D; Lingford-Hughes AR; Howes O. PREVIOUS COCAINE USE DECREASES PRESYNAPTIC LIMBIC DOPAMINERGIC FUNCTION: A [18F]-DOPA PET STUDY. 24:A57-A57. (Aug 2010).
  • Lingford-Hughes AR; Watson B; Daglish MR; Reid A; Williams TM; Wilson SJ; Taylor LG; Stokes P; et alNutt DJ. IMAGING THE ROLE OF DOPAMINE IN HUMAN OPIOID ADDICTS. 24:A8-A8. (Aug 2010).
  • Shotbolt JP; Stokes P; Howes OD; Grasby PM. STRIATAL DOPAMINE FUNCTION IN DIZYGOTIC TWIN PAIRS DISCORDANT FOR SCHIZOPHRENIA. 117:470-470. (Apr 2010). DOI.
  • Egerton A; Shotbolt JP; Stokes PR; Howes OD; Grasby PM. Effect of bupropion on extracellular dopamine levels in the striatum: a translational PET approach. 19:S313-S313. (Sep 2009).
  • Stokes PRA; Curran V; Grasby PM. Effects of THC on dopamine release in the human striatum: An 11C-raclopride PET study. 63:127S-127S. (1 Apr 2008).
  • Stokes PRA; Montgomery AJ; Kitamura Y; Grasby PM. The D-2 receptor system in depression: A PET investigation of extrastriatal binding and SSRI treatment. Summer Meeting of the British-Association-for-Psychoparmacology. 19:A57-A57. (Sep 2005).
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook